ClinicalTrials.Veeva

Menu

Training of a Artificial Intelligence Model to Detect Venous Diseases Using PPG Technology

T

The Whiteley Clinic

Status

Not yet enrolling

Conditions

Venous Disease

Treatments

Diagnostic Test: PPG Diagnostic

Study type

Observational

Funder types

Other

Identifiers

NCT06433024
TWC-SD-2024-05

Details and patient eligibility

About

This clinical research aims to evaluate the effectiveness of using Photoplethysmography (PPG) signals combined with Artificial Intelligence (AI) algorithms, for the precise classification and diagnosis of Venous Diseases of the lower limb. This study invites a group of participants who currently undergoing investigations for venous disease at The Whiteley Clinic (hereinafter referred to as TWC). The Participants will be classified into control (healthy individuals with no significant venous disease) and chronic venous disease (CVD) (diagnosed with proven venous disease) groups. Prospective participants who express an interest in being included in the study will be given a patient information sheet and will undergo a briefing of the pilot study. If they consent and sign the relevant consent forms, the participants will perform a series of standardized exercises under the supervision of a consultant vascular surgeon. Throughout the exercises, a data acquisition device attached to the ankle records the PPG signals, capturing the changes in blood volume due to the reflected PPG signals from the red blood cells during the movement. Thus, once the data is collected and recorded, this allows for the analysis of the data of the control group and CVD group against each other. During the analysis of the two groups' PPG signals, the objective lies within the capability to detect subtle nuances in the patterns of the PPG signals during the performed movements using AI algorithms. The AI algorithms will distinguish patterns or features indicating the presence or absence of venous disease. This study seeks to contribute valuable insights into enhancing the diagnosis of venous disease using PPG and AI algorithms, paving novel approaches to Venous healthcare.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients are attending for investigation of suspected venous disease. Patients must be able to walk and mobile normally and have good skin integrity of the lower leg, where the PPG is attached.

All patients attending TWC are 18 years or older.

Exclusion criteria

  • Subjects with known arterial occlusive disease or physical disability affecting gait or ankle movement will be excluded.

Patients unable to have a PPG attached to the lower leg (ie: active ulceration) will be excluded.

Patients unable to give consent. Pregnant female.

Trial design

20 participants in 2 patient groups

Individuals with CVD (Treatment Group)
Description:
Participants who have been diagnosed with Chronic Venous Disease (CVD).
Treatment:
Diagnostic Test: PPG Diagnostic
Individuals Without CVD (Control Group)
Description:
Participants who have not been diagnosed with CVD.
Treatment:
Diagnostic Test: PPG Diagnostic

Trial contacts and locations

1

Loading...

Central trial contact

Sergio Da Silva, PhD; Serah Duro, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems